Dr. Priyanka ChopraMD

Dr. Chopra specializes in functional and integrative internal medicine. Her primary clinical focus areas include gut health and microbiome restoration, hormonal optimization, autoimmune disease management, menopause and perimenopause care, metabolic health through the GLP-1 program, and advanced cancer screening. She also addresses chronic fatigue, brain fog, and chronic inflammation.

Yes. Dr. Chopra holds board certification in internal medicine. She also serves as Clinical Assistant Professor at the University of Miami Miller School of Medicine and previously held faculty status at NYU Langone Health.

Dr. Chopra treats a wide range of autoimmune conditions, including Hashimoto's thyroiditis, Graves' disease, lupus, rheumatoid arthritis, psoriasis, multiple sclerosis, inflammatory bowel disease, Crohn's disease, colitis, and celiac disease. She investigates root causes through advanced diagnostics rather than addressing symptoms in isolation.

Yes. Gut health and microbiome restoration sit at the center of Dr. Chopra's functional medicine practice. She evaluates patients using comprehensive stool analysis, food sensitivity testing, SIBO breath testing, and gut permeability testing. She treats bloating, IBS, food sensitivities, SIBO, leaky gut, and related digestive conditions.

Dr. Chopra leads Nivaan Health's hormone optimization program, which includes bioidentical hormone replacement therapy. She focuses on menopause and perimenopause care, addressing symptoms such as hot flashes, disrupted sleep, mood changes, vaginal dryness, and osteoporosis. Her approach pairs hormonal assessment with comprehensive biomarker testing.

Dr. Chopra previously served as Chief Medical Officer of a hybrid virtual healthcare company, where she directed clinical strategy across thousands of patient encounters. She also held a faculty position at NYU Langone Health before joining the University of Miami Miller School of Medicine, where she remains Clinical Assistant Professor.

Yes. Dr. Chopra leads Nivaan Health's GLP-1 metabolic transformation program. The program spans six months and pairs FDA-approved tirzepatide with MRI-based body composition tracking. She designs each protocol around the individual patient's metabolic profile and health goals.

Dr. Chopra uses a broad range of advanced diagnostics, including 100-plus biomarker panels, comprehensive stool analysis, food sensitivity testing, environmental toxin screening, SIBO breath testing, gut permeability testing, and hormonal assessments. She also coordinates Galleri multi-cancer blood testing and whole-body MRI screening for eligible members.